Back
Masimo Corp. 10K Form
Sell
19
MASI
Masimo Corp.
Last Price:
$142.22
Seasonality Move:
6.97%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-07 | 10Q | MASI/Masimo Corp. Quarterly |
| 2023-11-08 | 10Q | MASI/Masimo Corp. Quarterly |
| 2023-08-08 | 10Q | MASI/Masimo Corp. Quarterly |
| 2023-05-10 | 10Q | MASI/Masimo Corp. Quarterly |
| 2022-11-09 | 10Q | MASI/Masimo Corp. Quarterly |
| 2022-08-10 | 10Q | MASI/Masimo Corp. Quarterly |
Receive MASI News And Ratings
See the #1 stock for the next 7 days that we like better than MASI
MASI Financial Statistics
Sales & Book Value
| Annual Sales: | $2.1B |
|---|---|
| Cash Flow: | $49.7M |
| Price / Cash Flow: | 39.66 |
| Annual Sales: | $15.25 |
| Price / Book: | 9.16 |
Profitability
| EPS (TTM): | -10.60670 |
|---|---|
| Net Income (TTM): | $-203.8M |
| Gross Margin: | $1B |
| Return on Equity: | -19.18% |
| Return on Assets: | -8.33% |
Masimo Corp. Earnings Forecast
Key Masimo Corp. Financial Ratios
-
The Gross Profit Margin over the past 25 years for MASI is 47.96%.
-
The Selling, General & Administrative Expenses for MASI have been equal to 35.51% of Gross Profit Margin.
-
The Research & Development expenses have been 10.64% of Revenue.
-
The Net Earning history of MASI is -14.56% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 12 years.
Masimo Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | MASI |
| CUSIP: | 574795 |
| Website: | masimo.com |
Debt
| Debt-to-Equity Ratio: | 0.72 |
|---|---|
| Current Ratio: | 2.84 |
| Quick Ratio: | 1.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 112.16 |
|---|---|
| Forward P/E Ratio: | 23.53 |
MASI Technical Analysis vs Fundamental Analysis
Sell
19
Masimo Corp. (MASI)
is a Sell
Is Masimo Corp. a Buy or a Sell?
-
Masimo Corp. stock is rated a SellThe current Masimo Corp. [MASI] share price is $138.09. The Score for MASI is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.